CHRS
Coherus Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.96
−3.16%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.62x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.43x
- Price / sales
- 2.91x
- Price / cash flow
- -0.61x
Enterprise value
- Enterprise value
- $80.5M
- EV / sales
- 1.58x
- EV / EBITDA
- -0.54x
- EV / EBIT
- -0.51x
- Market cap
- $148.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026